ChaseDog31 Wednesday, 10/14/20 02:40:53 PM Re: NewJerichoMan post# 17162 Post # of 17534 I'm excited. We knew the vast majority of the current value of NDTP was in the CCA tech. Now it appears all that tech may be owned by our company, which makes our shares more valuable IMO. We of course need to confirm that when the filings drop. A $110 million market cap is peanuts for a pharmaceutical company with cutting edge technology and heavy hitters running the show. And don't forget about Kester and all of his fresh cutting edge tech that targets tumors, etc. I am jacked and will be buying more. This is a screaming buy under $10 IMO. Could be a fun Thursday and Friday around these parts.